CryoLife Inc (NYSE:CRY)

26.90
Delayed Data
As of 4:02pm ET
 -0.05 / -0.19%
Today’s Change
16.80
Today|||52-Week Range
27.45
+40.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$910.3M

Company Description

CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes BioGlue; BioFoam; On-X products; CardioGenesis cardiac laser therapy; PerClot; PhotoFix, Hemodialysis Reliable Outflow Graft; and ProCol Vascular Bioprosthesis. The Preservation Services segment offers preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Contact Information

CryoLife, Inc.
1655 Roberts Boulevard NW
Kennesaw Georgia 30144-3632
P:(770) 419-3355
Investor Relations:

Employees

Shareholders

Mutual fund holders42.82%
Other institutional25.17%
Individual stakeholders17.26%

Top Executives

James Patrick MackinChairman, President & Chief Executive Officer
David Ashley LeeChief Operating & Financial Officer, Executive VP
Scott B. CappsVice President-Clinical Research
Jean F. HollowaySecretary, Chief Compliance Officer & Senior VP
James McDermidChief Human Resources Officer & Senior VP